Eisai Net Income 2006-2019 | ESALY

Eisai annual/quarterly net income history and growth rate from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Eisai net income for the quarter ending December 31, 2019 was $M, a 100% decline year-over-year.
  • Eisai net income for the twelve months ending December 31, 2019 was $0.399B, a 21.24% decline year-over-year.
  • Eisai annual net income for 2020 was $1.12B, a 96.37% increase from 2019.
  • Eisai annual net income for 2019 was $0.57B, a 22.26% increase from 2018.
  • Eisai annual net income for 2018 was $0.467B, a 27.48% increase from 2017.
Eisai Annual Net Income
(Millions of US $)
2020 $1,120
2019 $570
2018 $467
2017 $366
2016 $456
2015 $394
2014 $330
2013 $584
2012 $743
2011 $812
2010 $436
2009 $477
2008 $-170
2007 $598
2006 $571
2005 $519
Eisai Quarterly Net Income
(Millions of US $)
2019-12-31
2019-06-30 $197
2018-06-30 $113
2017-06-30 $88
2016-06-30 $184
2015-06-30 $45
2015-03-31 $55
2014-12-31 $223
2014-09-30 $46
2014-06-30 $55
2014-03-31 $34
2013-12-31 $18
2013-09-30 $184
2013-06-30 $96
2013-03-31 $155
2012-12-31 $117
2012-09-30 $160
2012-06-30 $148
2012-03-31 $120
2011-12-31 $205
2011-09-30 $256
2011-06-30 $166
2011-03-31 $0
2010-12-31 $334
2010-09-30 $467
2010-06-30 $178
2010-03-31 $-146
2009-12-31 $255
2009-09-30 $156
2009-06-30 $164
2009-03-31 $94
2008-12-31 $105
2008-09-30 $109
2008-06-30 $166
2008-03-31 $-805
2007-12-31 $217
2007-09-30 $160
2007-06-30 $155
2007-03-31 $118
2006-12-31 $187
2006-09-30 $150
2006-06-30 $143
2006-03-31 $101
2005-12-31 $198
2005-09-30 $137
2005-06-30 $134
2005-03-31 $114
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $23.358B $6.400B
Eisai Co LTD is involved in the Biotechnology and Drug Industry. Their principle activities are the manufacture and sale of pharmaceutical products. Operations are carried out through the following divisions: Pharmaceuticals: veterinary drugs other food additives, livestock feed and pharmaceutical production systems and equipment. The Group has overseas consolidated subsidiaries in the United States, Canada, the United Kingdom, France, Germany, East Southeast Asia and South and Central America.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.380B 37.10
Takeda Pharmaceutical (TAK) Japan $56.087B 9.83
Astellas Pharma (ALPMY) Japan $30.738B 0.00
UCB SA (UCBJF) Belgium $22.796B 0.00
Merck (MKGAF) Germany $15.419B 0.00
Grifols, S.A (GRFS) Spain $12.857B 15.98
Neurocrine Biosciences (NBIX) United States $11.643B 53.81
Catalent (CTLT) United States $11.267B 43.56
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.469B 45.03
IPSEN SA ADR (IPSEY) France $7.049B 0.00
Orion OYJ (ORINY) Finland $6.766B 30.32
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.074B 9.72
United Therapeutics (UTHR) United States $5.296B 10.04
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.498B 491.11
Nektar Therapeutics (NKTR) United States $4.186B 0.00
Evotec AG (EVTCY) Germany $4.104B 110.61
FibroGen (FGEN) United States $3.876B 0.00
Hypermarcas (HYPMY) Brazil $3.819B 0.00
ChemoCentryx (CCXI) United States $3.588B 0.00
PTC Therapeutics (PTCT) United States $3.470B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.581B 10.60
Sage Therapeutics (SAGE) United States $2.233B 0.00
Pacira BioSciences (PCRX) United States $2.206B 45.15
Cronos Group (CRON) Canada $2.152B 61.70
Corcept Therapeutics (CORT) United States $1.969B 19.52
Xencor (XNCR) United States $1.871B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.752B 0.00
USANA Health Sciences (USNA) United States $1.729B 17.74
Akebia Therapeutics (AKBA) United States $1.704B 0.00
Indivior (INVVY) United States $1.679B 20.84
Ironwood Pharmaceuticals (IRWD) United States $1.622B 12.41
Zogenix (ZGNX) United States $1.615B 0.00
Karyopharm Therapeutics (KPTI) United States $1.441B 0.00
Portola Pharmaceuticals (PTLA) United States $1.415B 0.00
Heron Therapeutics (HRTX) United States $1.408B 0.00
Esperion Therapeutics (ESPR) United States $1.407B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.353B 14.58
Theravance Biopharma (TBPH) Cayman Islands $1.295B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.124B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.999B 44.59
BioCryst Pharmaceuticals (BCRX) United States $0.886B 0.00
Tilray (TLRY) Canada $0.869B 0.00
ImmunoGen (IMGN) United States $0.851B 0.00
Endo (ENDP) Ireland $0.802B 1.24
Radius Health (RDUS) United States $0.657B 0.00
Trillium Therapeutics (TRIL) Canada $0.657B 0.00
Aerie Pharmaceuticals (AERI) United States $0.649B 0.00
Ardelyx (ARDX) United States $0.624B 0.00
Molecular Templates (MTEM) United States $0.618B 0.00
Collegium Pharmaceutical (COLL) United States $0.600B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.576B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.556B 0.00
VAXART, INC (VXRT) United States $0.547B 0.00
Flexion Therapeutics (FLXN) United States $0.511B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.497B 12.02
Siga Technologies (SIGA) United States $0.484B 0.00
Innate Pharma SA (IPHYF) France $0.476B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.458B 17.89
DURECT (DRRX) United States $0.439B 0.00
Ocular Therapeutix (OCUL) United States $0.426B 0.00
Harpoon Therapeutics (HARP) United States $0.415B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.399B 0.00
Organogenesis Holdings (ORGO) United States $0.395B 0.00
TherapeuticsMD (TXMD) United States $0.378B 0.00
MEI Pharma (MEIP) United States $0.370B 0.00
Calithera Biosciences (CALA) United States $0.363B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.322B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.298B 0.00
OptiNose (OPTN) United States $0.296B 0.00
Lannett Co Inc (LCI) United States $0.287B 6.30
PROFOUND MEDICL (PROF) Canada $0.281B 0.00
Concert Pharmaceuticals (CNCE) United States $0.275B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.250B 0.00
CASI Pharmaceuticals (CASI) United States $0.245B 0.00
Redhill Biopharma (RDHL) Israel $0.239B 0.00
KalVista Pharmaceuticals (KALV) United States $0.231B 0.00
Jounce Therapeutics (JNCE) United States $0.222B 5.29
Rafael Holdings (RFL) United States $0.222B 0.00
Taiwan Liposome (TLC) Taiwan $0.215B 0.00
Nivalis Therapeutics (ALPN) United States $0.189B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 23.33
IMV INC (IMV) Canada $0.176B 0.00
Altimmune (ALT) United States $0.162B 0.00
Aquestive Therapeutics (AQST) United States $0.158B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.147B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.120B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.110B 0.00
Recro Pharma (REPH) United States $0.108B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.106B 0.00
Xeris Pharmaceuticals (XERS) United States $0.105B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.102B 0.00
Onconova Therapeutics (ONTX) United States $0.098B 0.00
Otonomy (OTIC) United States $0.098B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.096B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.092B 0.00
MediWound (MDWD) Israel $0.092B 0.00
CTI BioPharma (CTIC) United States $0.087B 0.00
Sundial Growers (SNDL) Canada $0.084B 0.00
Biomerica (BMRA) United States $0.083B 0.00
Heat Biologics (HTBX) United States $0.074B 0.00
SCYNEXIS (SCYX) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.067B 0.00
Aclaris Therapeutics (ACRS) United States $0.063B 0.00
Lipocine (LPCN) United States $0.063B 0.00
CV Sciences (CVSI) United States $0.060B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.052B 0.00
Infinity Pharmaceuticals (INFI) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.45
PolarityTE (PTE) United States $0.048B 0.00
Natural Alternatives (NAII) United States $0.047B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
GTx (ONCT) United States $0.042B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.71
Adamis Pharmaceuticals (ADMP) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.00
Novan (NOVN) United States $0.039B 0.00
Neos Therapeutics (NEOS) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 33.86
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Vical (BBI) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00